Aclaris Therapeutics (ACRS) EBT Margin Growth (3y) (2020 - 2026)
Powered by 
Analysis
Aclaris Therapeutics (ACRS) EBT Margin Growth (3y) (2020 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.78 Bn | 130.92 Bn | 2.84 Bn | -484.00 |
| 2 | Regeneron Pharmaceuticals | 85.50 Bn | 77.51 Bn | 3.93 Bn | 132.00 |
| 3 | Argenx Se | 63.51 Bn | 58.32 Bn | 1.37 Bn | 6,691.00 |
| 4 | Moderna | 58.06 Bn | 52.92 Bn | 52.00 Mn | -2,054.00 |
| 5 | Revolution Medicines | 44.04 Bn | 44.04 Bn | - | - |
| 6 | BeOne Medicines | 40.04 Bn | 34.94 Bn | 1.53 Bn | 8,006.00 |
| 7 | Alnylam Pharmaceuticals | 35.45 Bn | 32.14 Bn | 992.69 Mn | 9,980.00 |
| 8 | Royalty Pharma | 28.41 Bn | 27.57 Bn | - | -5,319.00 |
| 9 | Insmed | 27.42 Bn | 26.26 Bn | 358.27 Mn | 31,363.00 |
| 10 | Aclaris Therapeutics | 878.55 Mn | 878.55 Mn | 1.41 Mn | 36,295.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 36,295.00 |
| Mar 31, 2026 | 12,601.00 |
| Dec 31, 2025 | -126,160.00 |
| Sep 30, 2025 | -35,420.00 |
| Jun 30, 2025 | 47,478.00 |
| Mar 31, 2025 | 25,870.00 |
| Dec 31, 2024 | 48,081.00 |
| Sep 30, 2024 | 102,790.00 |
| Jun 30, 2024 | 58,862.00 |
| Mar 31, 2024 | 90,096.00 |
| Dec 31, 2023 | 84,772.00 |
| Sep 30, 2023 | 40,863.00 |
| Jun 30, 2023 | -118,469.00 |
| Mar 31, 2023 | -6,419.00 |
| Dec 31, 2022 | 123,646.00 |
| Sep 30, 2022 | 221,779.00 |
| Jun 30, 2022 | 352,049.00 |
| Mar 31, 2022 | 78,639.00 |
| Dec 31, 2021 | -88,570.00 |
| Sep 30, 2021 | 68,010.00 |